Division of Dermatology and Venereology, Geneva University Hospitals, and Faculty of Medicine, Geneva, Switzerland.
Department of Woman, Child and Adolescent, Geneva University Hospitals, and Faculty of Medicine, Geneva, Switzerland.
Swiss Med Wkly. 2024 Nov 1;154:3678. doi: 10.57187/s.3678.
Congenital syphilis is a rare complication of syphilis in pregnant women. Vertical transmission may occur at any time during pregnancy. The incidence of congenital syphilis has been increasing worldwide. Congenital syphilis has been a notifiable disease for many years in Switzerland but reporting does not include maternal features associated with syphilis in pregnancy or infant's subsequent development. We described syphilis cases among pregnant women screened over a 10-year period in Switzerland and subsequent cases of congenital syphilis, in order to identify maternal risk profiles and to optimise prevention. Second, we compared the characteristics of pregnant women screened early (1st trimester) vs late in pregnancy (2nd or 3rd trimester). Finally, we assessed the risk factors for premature birth among these women with syphilis.
A multicentre retrospective study conducted in Swiss hospitals from 2012 to 2021, including pregnant women who screened positive for syphilis (Treponema pallidum haemagglutination assay [TPHA] / T. pallidum particle agglutination assay [TPPA ] ≥1:80) and newborns exposed to T. pallidum in utero and/or congenitally infected and with a positive syphilis serology at birth. Data were collected from medical records.
A total of 147 syphilis-positive pregnant women and 102 infants were included. A history of treated syphilis was known for 44% (65/147) of the mothers corresponding to a serological scar and the remaining 56% (82/147) were newly identified syphilis cases. Syphilis screening was done during the first trimester in 54%, second trimester in 29% and third trimester in 13% of cases. Two babies were diagnosed with congenital syphilis (1.96%). Several potential factors that could contribute to women's risk of syphilis during pregnancy were identified such as a foreign origin (93% of mothers), lack of healthcare insurance (25%), no employment status (37%), drug use (5%), co-infection with other sexually transmitted infections (24%) and a late first antenatal consultation (42%). The number of pregnant women without insurance was higher in women diagnosed in the second or third trimester than in those diagnosed in the first trimester (odds ratio 0.41; 95% CI 0.19-0.89; p = 0.024). Syphilis diagnosed in the second or third trimester was associated with a late first antenatal consultation (odds ratio 77.82; 95% CI 9.81-617.21; p <0.001). A high rate of intrauterine growth retardation and of preterm birth was observed in newborns (18% versus 6% in Switzerland in 2022).
Congenital syphilis remains rare in Switzerland. However, we found potential maternal factors associated with a positive syphilis serology during pregnancy, which can help to improve future prevention measures. The study protocol was registered on ClinicalTrials.gov (ID NCT05975502).
先天性梅毒是孕妇梅毒的一种罕见并发症。垂直传播可能发生在怀孕期间的任何时间。先天性梅毒的发病率在全球范围内呈上升趋势。先天性梅毒在瑞士多年来一直是一种法定报告疾病,但报告不包括与妊娠期间梅毒相关的母体特征或婴儿随后的发育情况。我们描述了瑞士在过去 10 年期间筛查出的孕妇梅毒病例,以及随后的先天性梅毒病例,以便确定母体的风险特征并优化预防措施。其次,我们比较了早期(妊娠 1 期)和晚期(妊娠 2 期或 3 期)筛查的孕妇的特征。最后,我们评估了这些患有梅毒的孕妇早产的风险因素。
这是一项在瑞士医院进行的多中心回顾性研究,时间跨度为 2012 年至 2021 年,纳入了梅毒螺旋体血凝试验(Treponema pallidum haemagglutination assay [TPHA] / T. pallidum particle agglutination assay [TPPA] ≥1:80)阳性的孕妇和暴露于梅毒螺旋体的新生儿宫内和/或先天感染以及在出生时梅毒血清学呈阳性的新生儿。数据从病历中收集。
共纳入 147 例梅毒阳性孕妇和 102 例婴儿。母亲中有 44%(65/147)有治疗过的梅毒史,对应血清学疤痕,其余 56%(82/147)为新发现的梅毒病例。梅毒筛查在 54%的病例中在妊娠早期进行,29%的病例在妊娠中期进行,13%的病例在妊娠晚期进行。有 2 例婴儿被诊断为先天性梅毒(1.96%)。确定了一些可能导致孕妇在怀孕期间感染梅毒的潜在因素,如外来血统(93%的母亲)、缺乏医疗保健保险(25%)、无就业状态(37%)、药物使用(5%)、合并其他性传播感染(24%)和首次产前咨询较晚(42%)。在妊娠 2 或 3 期诊断的孕妇中,没有保险的孕妇人数高于妊娠 1 期诊断的孕妇(比值比 0.41;95%置信区间 0.19-0.89;p=0.024)。妊娠 2 或 3 期诊断的梅毒与首次产前咨询较晚相关(比值比 77.82;95%置信区间 9.81-617.21;p<0.001)。新生儿存在宫内生长迟缓率和早产率高(18%与 2022 年瑞士的 6%)。
先天性梅毒在瑞士仍然很少见。然而,我们发现了与孕妇妊娠期间梅毒血清学阳性相关的潜在母体因素,这有助于改善未来的预防措施。研究方案在 ClinicalTrials.gov 上注册(ID NCT05975502)。